Navigation Links
Screening for Ischemia in Asymptomatic Patients With Type 2 Diabetes: Five- Year Outcomes in the DIAD Study

Study Shows Systematic Screening May Not Be Necessary For Diabetic Patients

BOSTON, Sept. 13 /PRNewswire-USNewswire/ -- There are 21 million patients with Type 2 diabetes in the United States alone. Coronary artery disease (CAD) is a major cause of morbidity in patients with diabetes. Silent myocardial ischemia is common, and cardiac death or myocardial infarction may be the first manifestation of CAD.

Data from the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study, presented today at the American Society of Nuclear Cardiology Annual Scientific Session, seeks to assess the prevalence of silent myocardial ischemia and discern whether CAD screening should be offered to all people with type 2 diabetes. According to the most recent information from the study, screening does not provide a significant benefit to this patient population.

"The DIAD study is the first large prospective study addressing the issue of whether a strategy of systematic screening for silent coronary artery disease alters cardiac outcome," said Dr. Frans Wackers, who will present results from the study at today's meeting.

Overall, 1,123 diabetic patients without symptomatic or previously diagnosed CAD were randomized to either screening with myocardial perfusion imaging or standard care without screening. After an average 5-year follow- up, researchers found a low overall cardiac event rate and no difference between the two groups. Thus, unexpectedly, diabetic patients without known CAD have an overall highly favorable five-year prognosis with contemporary therapy, such as aspirin, statins, and ACE-inhibitors.

"Systematic screening cannot be recommended in asymptomatic patients with diabetes," commented Dr. Wackers. "However, targeted screening, involving close clinical follow-up and clinically driven diagnostic testing, is appropriate. Using the latter approach, about 30% of initially asymptomatic patients had stress myocardial perfusion imaging in the standard-care arm of the DIAD study."

Dr. Frans Wackers will present this study, "Screening for Ischemia in Asymptomatic Patients with Type 2 Diabetes: Five-Year Outcomes in the DIAD Study" Saturday, September 13, 2008 at 11:40 a.m. in Room 306.

The American Society of Nuclear Cardiology (ASNC) is the leader in education, advocacy, and quality for the field of nuclear cardiology. Serving more than 5,000 individuals in over 50 countries, ASNC is the only professional association dedicated to the dynamic subspecialty of nuclear cardiology.

SOURCE American Society of Nuclear Cardiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
2. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
3. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
4. Innovative Brain Scanning for Alzheimers Screening Unveiled
5. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
6. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
7. Lung Cancer Alliance Commends NCCN on Screening Guidelines
8. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
9. Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
10. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
11. Task Force Recommends Screening for Hearing Loss in All Newborns
Post Your Comments:
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):